CR20160495A - Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas - Google Patents

Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas

Info

Publication number
CR20160495A
CR20160495A CR20160495A CR20160495A CR20160495A CR 20160495 A CR20160495 A CR 20160495A CR 20160495 A CR20160495 A CR 20160495A CR 20160495 A CR20160495 A CR 20160495A CR 20160495 A CR20160495 A CR 20160495A
Authority
CR
Costa Rica
Prior art keywords
making
methods
same
cell free
free compositions
Prior art date
Application number
CR20160495A
Other languages
English (en)
Spanish (es)
Inventor
Steve Greco
Vincent C Giampapa
Original Assignee
Advanced Regen Medical Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/577,978 external-priority patent/US20150174166A1/en
Application filed by Advanced Regen Medical Tech Llc filed Critical Advanced Regen Medical Tech Llc
Publication of CR20160495A publication Critical patent/CR20160495A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CR20160495A 2014-03-24 2015-03-24 Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas CR20160495A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461969694P 2014-03-24 2014-03-24
US14/577,978 US20150174166A1 (en) 2013-12-20 2014-12-19 Compositions for Cellular Restoration and Methods of Making and Using Same
PCT/US2015/022285 WO2015148534A1 (en) 2014-03-24 2015-03-24 Cell free compositions for cellular restoration and methods of making and using same

Publications (1)

Publication Number Publication Date
CR20160495A true CR20160495A (es) 2017-05-29

Family

ID=54196315

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20160495A CR20160495A (es) 2014-03-24 2015-03-24 Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas

Country Status (4)

Country Link
EP (2) EP4445915A3 (https=)
JP (2) JP6471302B2 (https=)
CR (1) CR20160495A (https=)
WO (1) WO2015148534A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11286463B2 (en) 2012-03-08 2022-03-29 Advanced ReGen Medical Technologies, LLC Reprogramming of aged adult stem cells
US20150174166A1 (en) 2013-12-20 2015-06-25 Advanced ReGen Medical Technologies, LLC Compositions for Cellular Restoration and Methods of Making and Using Same
US10772911B2 (en) 2013-12-20 2020-09-15 Advanced ReGen Medical Technologies, LLC Cell free compositions for cellular restoration and methods of making and using same
US11203754B2 (en) 2016-04-29 2021-12-21 Advanced ReGen Medical Technologies, LLC Microrna compositions and methods of making and using same
EP3740576A4 (en) 2018-01-18 2021-10-20 Advanced Regen Medical Technologies, LLC THERAPEUTIC COMPOSITIONS AND THEIR PREPARATION AND USE METHODS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008501336A (ja) * 2004-06-02 2008-01-24 ソースフアーム・インコーポレイテツド Ｒｎａを含有する微小胞およびそのための方法
US8693760B2 (en) * 2009-06-25 2014-04-08 Hitachi Medical Corporation Medical imaging apparatus
EP2363136A1 (en) * 2010-03-02 2011-09-07 Fresenius Medical Care Deutschland GmbH Microvesicles (MVs) derived from adult stem cells for use in the therapeutic treatment of a tumor disease
US20120093885A1 (en) * 2010-10-18 2012-04-19 Northwestern University Therapeutic vesicles
US8747915B1 (en) 2011-09-14 2014-06-10 Vincent C. Giampapa Dietary supplement system for multifunctional anti-aging management and method of use
WO2013066368A1 (en) * 2011-10-03 2013-05-10 The United States Of America, As Represented By The Secretary, Dept. Of Health And Human Services Use of mirna 126 to produce hematopoietic stem cells
US9427450B2 (en) * 2012-01-31 2016-08-30 Xon Cells, Inc. Therapeutic immune modulation by stem cell secreted exosomes
US9295696B2 (en) * 2012-06-08 2016-03-29 University of Pittsburgh—of the Commonwealth System of Higher Education Compositions and methods for restoring or rejuvenating stem/progenitor cell function
EP3563859B1 (en) * 2012-08-13 2021-10-13 Cedars-Sinai Medical Center Cardiosphere-derived exosomes for tissue regeneration

Also Published As

Publication number Publication date
EP4445915A3 (en) 2025-01-22
EP3122333A1 (en) 2017-02-01
JP6900358B2 (ja) 2021-07-07
WO2015148534A1 (en) 2015-10-01
EP4445915A2 (en) 2024-10-16
JP2017510582A (ja) 2017-04-13
JP6471302B2 (ja) 2019-02-20
EP3122333A4 (en) 2017-11-29
JP2019052182A (ja) 2019-04-04

Similar Documents

Publication Publication Date Title
NZ728072A (en) Modulators of toll-like receptors for the treatment of hiv
MX2016013457A (es) Inhibidores de mdm2 y metodos terapeuticos que utilizan el mismo.
MX390014B (es) Compuestos de dinucleótidos cíclicos y métodos de uso.
CL2016002269A1 (es) Moduladores alostéricos del núcleo proteico de la hepatitis b.
EA201591887A1 (ru) Макроциклические деазаоксипурины для лечения вирусных инфекций
MX2023003875A (es) Formulacion de una vacuna peptidica.
MX2017001512A (es) Compuestos activos hacia bromodominios.
MX2017007641A (es) Conjugados de anticuerpo-farmaco con inhibidores de bcl-xl permeables en las celulas.
EA201592103A3 (ru) Способы и композиции для усиления cd4+ регуляторных t-клеток
BR112015022625A2 (pt) micromatrizes para entrega de agente terapêutico e métodos de uso
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
EA202090098A1 (ru) Фармацевтические композиции терапевтически активных соединений
CL2015002897A1 (es) Inhibidores de bace1
IN2013MU03583A (https=)
EA201790650A1 (ru) Лекарственная форма и способы применения абиратерона ацетата
EA201591752A1 (ru) Дипептидные и трипептидные эпоксикетонные ингибиторы протеазы
MX389178B (es) Formulacion de proporcion fija de insulina glargina/lixisenatida.
MX2015012416A (es) Compuestos heterociclicos y sus usos.
CL2017003437A1 (es) Formulación solida oral que contiene irinotecán y método de preparación de la misma
MX373309B (es) Composiciones antibióticas de ceftolozano.
EA201692043A1 (ru) Лекарственная форма иммунодепрессанта
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
TR201821116A2 (tr) POSAKONAZOL İÇEREN FARMASÖTİK BİLEŞİMLER ve ÜRETİM YÖNTEMİ
CR20160495A (es) Composiciones libres de células para la restauración de células y métodos para la preparación y utilización de las mismas